The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

The Agency for Health Care Administration revised the public notice published Sept. 30, 2025, in Vol. 51 No. 190 of the ...

Meanwhile, herd immunity among children is decreasing. In today’s issue: The Trump administration reduces the number of shots recommended for children. … The Justice Department defends Medicare’s drug ...

Scientists from the Institute of Molecular Genetics of the Czech Academy of Sciences, in collaboration with the Faculty of ...

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity on both tumor growth and cancer cell spread. MIAMI, FLORIDA / ACCESS ...

Novo Nordisk has launched its new Wegovy pill, the first GLP-1 pill approved by the U.S. Food & Drug Administration (FDA) to ...

Researchers have identified a single protein whose absence can cripple tumors in mice, slowing their growth and in some cases ...

With Houston ISD students returning to classes Tuesday, here's what to expect from the state's largest school district in ...

Immune checkpoint molecules play a crucial role in keeping the immune system in balance and preventing an attack on the ...

Novo Nordisk is launching its once-daily Wegovy pill in the U.S. on Monday, offering 1.5- and 4-milligram doses at $149 per ...

This important study introduces a new biology-informed strategy for deep learning models aiming to predict mutational effects in antibody sequences. It provides solid evidence that separating ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter: Alumis: Top-line ...